TruScreen Group Limited (TRU.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -2.72 Million NZD | -26.27% |
| 2023 | -2.16 Million NZD | 22.76% |
| 2022 | -2.79 Million NZD | 46.78% |
| 2021 | -5.25 Million NZD | -756.05% |
| 2020 | -613.87 Thousand NZD | 44.76% |
| 2019 | -1.11 Million NZD | 8.35% |
| 2018 | -1.21 Million NZD | 66.98% |
| 2017 | -3.67 Million NZD | -59.31% |
| 2016 | -2.3 Million NZD | -1722.11% |
| 2015 | -126.48 Thousand NZD | 93.91% |
| 2014 | -2.07 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -2.72 Million NZD | -26.27% |
| 2024 Q4 | -2.72 Million NZD | 0.0% |
| 2024 Q1 | -807.22 Thousand NZD | 62.64% |
| 2024 Q2 | -807.22 Thousand NZD | 0.0% |
| 2024 Q3 | -2.72 Million NZD | -237.95% |
| 2023 Q4 | -2.16 Million NZD | 0.0% |
| 2023 Q3 | -2.16 Million NZD | -28.79% |
| 2023 Q2 | -1.67 Million NZD | 0.0% |
| 2023 Q1 | -1.67 Million NZD | 40.02% |
| 2023 FY | -2.16 Million NZD | 22.76% |
| 2022 Q4 | -2.79 Million NZD | 0.0% |
| 2022 Q2 | -3.67 Million NZD | 0.0% |
| 2022 FY | -2.79 Million NZD | 46.78% |
| 2022 Q1 | -3.67 Million NZD | 30.1% |
| 2022 Q3 | -2.79 Million NZD | 23.86% |
| 2021 Q3 | -5.25 Million NZD | -30.37% |
| 2021 Q4 | -5.25 Million NZD | 0.0% |
| 2021 FY | -5.25 Million NZD | -756.05% |
| 2021 Q1 | -4.03 Million NZD | -556.62% |
| 2021 Q2 | -4.03 Million NZD | 0.0% |
| 2020 Q4 | -613.87 Thousand NZD | 0.0% |
| 2020 FY | -613.87 Thousand NZD | 44.76% |
| 2020 Q3 | -613.87 Thousand NZD | -68.5% |
| 2020 Q2 | -364.32 Thousand NZD | 0.0% |
| 2020 Q1 | -364.32 Thousand NZD | 67.22% |
| 2019 FY | -1.11 Million NZD | 8.35% |
| 2019 Q4 | -1.11 Million NZD | 0.0% |
| 2019 Q3 | -1.11 Million NZD | 24.81% |
| 2019 Q1 | -1.47 Million NZD | -21.89% |
| 2019 Q2 | -1.47 Million NZD | 0.0% |
| 2018 Q1 | -2.63 Million NZD | 28.35% |
| 2018 FY | -1.21 Million NZD | 66.98% |
| 2018 Q4 | -1.21 Million NZD | 0.0% |
| 2018 Q3 | -1.21 Million NZD | 53.91% |
| 2018 Q2 | -2.63 Million NZD | 0.0% |
| 2017 Q1 | -1.41 Million NZD | 38.81% |
| 2017 Q4 | -3.67 Million NZD | 0.0% |
| 2017 FY | -3.67 Million NZD | -59.31% |
| 2017 Q2 | -1.41 Million NZD | 0.0% |
| 2017 Q3 | -3.67 Million NZD | -160.33% |
| 2016 Q2 | -3.7 Million NZD | 0.0% |
| 2016 FY | -2.3 Million NZD | -1722.11% |
| 2016 Q4 | -2.3 Million NZD | 0.0% |
| 2016 Q3 | -2.3 Million NZD | 37.79% |
| 2016 Q1 | -3.7 Million NZD | -2828.99% |
| 2015 Q3 | -126.48 Thousand NZD | 91.4% |
| 2015 Q1 | -1.47 Million NZD | 0.0% |
| 2015 FY | -126.48 Thousand NZD | 93.91% |
| 2015 Q2 | -1.47 Million NZD | 0.0% |
| 2015 Q4 | -126.48 Thousand NZD | 0.0% |
| 2014 FY | -2.07 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 89.296% |
| Adherium Limited | -6.1 Million AUD | 55.31% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 27.197% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 24.291% |
| Anteris Technologies Ltd | -28.49 Million AUD | 90.428% |
| Control Bionics Limited | -19.02 Thousand AUD | -14241.478% |
| CardieX Limited | 2.74 Million AUD | 199.334% |
| Compumedics Limited | 5.08 Million AUD | 153.628% |
| Cochlear Limited | -269.9 Million AUD | 98.989% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 490.505% |
| Cyclopharm Limited | -7.49 Million AUD | 63.622% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 82.625% |
| Nova Eye Medical Limited | -2.8 Million AUD | 2.64% |
| HeraMED Limited | -799.34 Thousand AUD | -241.283% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 118.836% |
| ImpediMed Limited | -23.48 Million AUD | 88.386% |
| InhaleRx Limited | -155.54 Thousand AUD | -1653.868% |
| LBT Innovations Limited | -604 Thousand AUD | -351.662% |
| Micro-X Limited | 826.99 Thousand AUD | 429.872% |
| Neurotech International Limited | -2.11 Million AUD | -29.261% |
| OncoSil Medical Limited | -4.43 Million AUD | 38.429% |
| PolyNovo Limited | -30.52 Million AUD | 91.064% |
| Respiri Limited | 413.68 Thousand AUD | 759.441% |
| SomnoMed Limited | -15.16 Million AUD | 82.008% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 48.566% |
| Uscom Limited | -1.53 Million AUD | -78.229% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 33.185% |